GC12 -辅助多西紫杉醇对中高危前列腺癌根治性放疗后的监测：SPCG-13试验的最终10年生存结果

{"title":"GC12 -辅助多西紫杉醇对中高危前列腺癌根治性放疗后的监测：SPCG-13试验的最终10年生存结果","authors":"P.L. Kellokumpu-Lehtinen, T. Huttunen, I. Lehtinen, C. Thellenberg-Karlsson","doi":"10.1016/j.eururo.2025.09.4127","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"43 1","pages":""},"PeriodicalIF":25.2000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GC12 – Adjuvant docetaxel versus surveillance in intermediate or high-risk prostate cancer after radical curative radiotherapy: The final 10-year survival results of the SPCG-13 trial\",\"authors\":\"P.L. Kellokumpu-Lehtinen, T. Huttunen, I. Lehtinen, C. Thellenberg-Karlsson\",\"doi\":\"10.1016/j.eururo.2025.09.4127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12223,\"journal\":{\"name\":\"European urology\",\"volume\":\"43 1\",\"pages\":\"\"},\"PeriodicalIF\":25.2000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.eururo.2025.09.4127\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eururo.2025.09.4127","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}